REGENXBIO
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell REGENXBIO and other ETFs, options, and stocks.About RGNX
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381.
RGNX Key Statistics
Stock Snapshot
REGENXBIO(RGNX) stock is priced at $8.46, giving the company a market capitalization of 428.27M. It carries a P/E multiple of -2.39.
On 2026-02-13, REGENXBIO(RGNX) stock traded between a low of $8.17 and a high of $8.63. Shares are currently priced at $8.46, which is +3.5% above the low and -2.0% below the high.
REGENXBIO(RGNX) shares are trading with a volume of 405.06K, against a daily average of 1.08M.
During the past year, REGENXBIO(RGNX) stock moved between $5.04 at its lowest and $16.19 at its peak.
During the past year, REGENXBIO(RGNX) stock moved between $5.04 at its lowest and $16.19 at its peak.
Analyst ratings
92%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.